Takeaway
Distinct cognitive profiles are identified in people with clinically diagnosed probable Alzheimer’s disease (AD) and these are differentially associated with tangle pathology and distinct rates of decline.
Why this matters
Cognitive heterogeneity in probable AD could have implications for clinical trials, particularly therapies targeting tau.